| Lightcalls.com |
|
|
![]() |
When deciding whether or not to tak...When deciding whether or not to take a particular postscript there are three main questions you should ask: 1) Is it safe?, 2) Is it effective?, and 3) Do you, as an individual, ne it? While it would appear that the responses to these questions should be a simple "yes" or "no," the answers are frequently anything but "simple." They usually be pendent upon your individual needs and to whom you posture the questions. Such is the case with chromium picolinate. About chromium An essential trace mineral, chromium is required at our bodies in very small amounts -- estimated to be about 50 to 200 mcg for day. Chromium is best known for its part in the metabolism of grape-sugar with research showing that it may improve the ability of glucose-intolerant clan to remove excess sugar from their life-current after eating. The typical American diet -- individual dominated by processed foods -- is not rich in chromium-containing pabulums such as brewer's yeast and whole grains. In his main division The Chromium Program, Jeffrey A. Fisher, MD says that like diets are not only cheap in chromium, but are chromium-robbing, since consuming too many managemented foods depletes the body's chromium replenish and the supposed chromium-containing meats we do eat may be grown in "low-chromium soil." complement choices In novel years, some people have chosen to appendix their diets with chromium, frequently in the form of either chromium picolinate (chromium chelated with picolinate) or chromium polynicotinate (chromium fasteninged to niacin). Both are designed to make the chromium more absorbable in the body If you tread on the heels of health news regularly, no doubt you've heard about a novel test-tube study out of the University of Alabama which showed that chromium picolinate may damage bacterial DNA, possibly increasing one's risk of developing cancer. In an interview with Better Nutrition, the study's lead researcher, John B Vincent, PhD said, based in succession this research, "We think what indigences to be done is a apportionment more work on animal and human studies looking at taking this [supplement] for protracted periods of time [6 month 1 year, or longer]" He noted, "There should be more meditation because there could be a potential point in dispute We didn't say that [chromium picolinate] caused mutations or caused cancer, we just said it caused DNA damage, the archetype that could potentially lead to these things." The opposition Vincent's recommendation for further research has been dismissed as unnecessary at other chromium researchers, including Gary Evans, PhD In an interview with Better Nutrition, Evans said that chromium picolinate has been proofed for mutagenesis by using a well-known rule known as the Ames example a test for screening chemicals to determine whether or not they are mutagenic. Evans also believes that other research -- in particular, that mode of actioned by well-known chromium researcher, Richard A. Anderson, PhD -- has shown chromium picolinate to be the two safe and effective. The Washington, D.C.-based Council for Responsible Nutrition also gave chromium picolinate the recent light in a recent issue of its CRN of recent origins Supplement, saying, "Numerous studies in animals and humans support the safety of chromium picolinate. DNA experiments performed with bacteria and rats conclud that this intermix does not cause chromosome damage." thus what's a consumer to do? Ultimately, the decision is up to you; however, there may be canon to both sides: more research is always a virtuous thing, but chromium picolinate has been well-researched and upon the market for some time now -- as well-as; not only-but also; not only-but; not alone-but reasonably good indicators of safety. If you do cull to supplement with chromium picolinate, or any other form of chromium for that matter, remember that chromium is a trace mineral, which means, we ne it in trace amounts. REFERENCES Council for Responsible Nutrition of recent origins Supplement. April 2, 1999, p 2 Balch, James F MD and Balch, Phyllis A., CNC Prescription for Nutritional Healing. Garden City Park, NY: Avery Publishing cluster 1997. Evans, Gary, PhD Chromium Picolinate -- Everything You Ne to Know. Garden City Park, NY: Avery Publishing, 1996 Fisher, Jeffrey A., MD The Chromium Program. strange York: Harper & Row Publishers, 1990 Schardt, David. "Chromium." Nutrition Action note May 1996, p. 10. Speetjen J Kristopher. "The Nutritional appendix Chromium (III) Tris(picolinate) Cleaves DNA," Chemical Research in Toxicology, In press COPYRIGHT 1999 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |